›
^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersTEST:Empower™ Hereditary cancer test
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
NateraType:
Laboratory Developed Test
Related tests:
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower tests up to 53 genes associated with risk for common hereditary cancers using blood or saliva samples. Breast STAT panel results arrive in 5-7 days, with a full report in 2 weeks.
Cancer:
Breast Cancer, Colorectal Cancer, Endometrial Cancer, Melanoma, Ovarian Cancer
Gene:
ATM (ATM serine/threonine kinase), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1), CDH1 (Cadherin 1), CHEK2 (Checkpoint kinase 2)
See More ...
ATM (ATM serine/threonine kinase), BRCA1 (Breast cancer 1, early onset), BRCA2 (Breast cancer 2, early onset), BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1), CDH1 (Cadherin 1), CHEK2 (Checkpoint kinase 2), EPCAM (Epithelial cell adhesion molecule), MLH1 (MutL homolog 1), MSH2 (MutS Homolog 2), MSH6 (MutS homolog 6), NBN (Nibrin Nijmegen Breakage Syndrome 1 (Nibrin)), NF1 (Neurofibromin 1), PALB2 (Partner and localizer of BRCA2), PMS2 (PMS1 protein homolog 2), PTEN (Phosphatase and tensin homolog), RAD51C (RAD51 paralog C), RAD51D (RAD51 paralog D), STK11 (Serine/threonine kinase 11), TP53 (Tumor protein P53)
Method:
Next-Generation Sequencing (NGS)
